NAKAMIZO Nobuhiro | Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
スポンサーリンク
概要
- NAKAMIZO Nobuhiroの詳細を見る
- 同名の論文著者
- Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.の論文著者
関連著者
-
KUBO Kazuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
SHUTO Katsuichi
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
NAKAMIZO Nobuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
Karasawa Akira
Deparment Of Pharmacology Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Yamada Koji
Deparment Of Food Science And Technology Faculty Of Agriculture Kyushu University
-
KUBO Kazuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
SHUTO Katsuichi
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
NAKAMIZO Nobuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
KARASAWA Akira
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
YAMADA Koji
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
著作論文
- Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
- Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.